First reported 17 hours ago -
Updated 16 hours ago -
Antares Pharma, Inc. (NASDAQ: ATRS) today announced the issuance of U.S.Patents RE44846 and RE44847. These patents are reissued versions of U.S.Patents 7,744,582, and 7,776,015. Tracing back to inventions made in thelate 1990’s, the patents capture innovations ...
[Published 4 Traders - 17 hours ago]